These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 15467992)
1. [Restless legs syndrome in a patient with amputation of both legs]. Estivill E; de la Fuente-Pañell V; Segarra-Isern F; Albares-Tendero J Rev Neurol; 2004 Sep 16-30; 39(6):536-8. PubMed ID: 15467992 [TBL] [Abstract][Full Text] [Related]
5. Ropinirole treatment for restless legs syndrome. Chitnis S Expert Opin Drug Metab Toxicol; 2008 May; 4(5):655-64. PubMed ID: 18484922 [TBL] [Abstract][Full Text] [Related]
6. Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs. Hanna PA; Kumar S; Walters AS Clin Neuropharmacol; 2004; 27(2):87-9. PubMed ID: 15252270 [TBL] [Abstract][Full Text] [Related]
7. Ropinirole in restless leg syndrome. Ahmed I Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942 [TBL] [Abstract][Full Text] [Related]
8. Ropinirole treatment for restless legs syndrome. Molnar MZ; Fornadi K; Shapiro CM Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668 [TBL] [Abstract][Full Text] [Related]
9. [The efficacy of ropinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data]. Estivill E; de la Fuente V Rev Neurol; 1999 Nov 1-15; 29(9):805-7. PubMed ID: 10696651 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme. Giorgi L; Ritchie SY; Kirsch JM Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844 [TBL] [Abstract][Full Text] [Related]
11. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Happe S; Sauter C; Klösch G; Saletu B; Zeitlhofer J Neuropsychobiology; 2003; 48(2):82-6. PubMed ID: 14504416 [TBL] [Abstract][Full Text] [Related]
12. Severe restless legs syndrome in a family with Alport syndrome. Sparasci D; Rossinelli A; Ferri R; Cippà P; Rinaldi A; Manconi M BMC Nephrol; 2021 Jul; 22(1):249. PubMed ID: 34225668 [TBL] [Abstract][Full Text] [Related]
14. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations. Geyer J; Bogan R Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004 [TBL] [Abstract][Full Text] [Related]
15. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset. Allen RP; Ritchie SY Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167 [TBL] [Abstract][Full Text] [Related]
17. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Allen R; Becker PM; Bogan R; Schmidt M; Kushida CA; Fry JM; Poceta JS; Winslow D Sleep; 2004 Aug; 27(5):907-14. PubMed ID: 15453549 [TBL] [Abstract][Full Text] [Related]
18. Ropinirole for restless legs syndrome. Ondo W Mov Disord; 1999 Jan; 14(1):138-40. PubMed ID: 9918357 [TBL] [Abstract][Full Text] [Related]
19. Restless legs syndrome: pathophysiology and modern management. Nagandla K; De S Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988 [TBL] [Abstract][Full Text] [Related]
20. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. Bayard S; Langenier MC; Dauvilliers Y Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]